CXCR3 and autoimmune disease: Among the molecules which could represent potential targets for obtaining beneficial effects in the treatment of autoimmune diseases, there are the soluble CD83 (sCD83), a molecule able to negatively regulate NK cellular function in experimental autoimmune uveitis (EAU) (109) and the chemokine-receptor-3 (CXCR3) isoform B whose inhibition prevented melanocyte apoptosis and the further activation of T lymphocytes (108).